Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-08-26FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride CD from Lannett Company, Inc. The product is a controlled-delivery…
-
FDA approval · 2008-08-11FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's generic combination of four amphetamine salts: dextroamphetamine saccharate, amphetamine …
-
FDA approval · 2008-07-23FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for STRATTERA (atomoxetine hydrochloride) filed by Eli Lilly, resulting in updated labeling.
-
FDA approval · 2008-06-27FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2008-05-23FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) from Amneal Pharmaceuticals LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-05-07FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) from Eli Lilly and Company to update or expand its lab…
-
FDA approval · 2008-02-06FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for dextroamphetamine sulfate, a generic stimulant indicated for atte…
-
FDA approval · 2008-02-05FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
The FDA approved a supplemental application for the Methylphenidate Transdermal System (methylphenidate patch) from Padagis US LLC.
-
FDA approval · 2008-01-29FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Prasco Laboratories)
FDA approves a generic form of dextroamphetamine sulfate from Prasco Laboratories under an Original Application, for ADHD and narcolepsy ind…
-
FDA approval · 2008-01-16FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
FDA approves a supplemental application from SpecGx LLC for a dextroamphetamine sulfate extended-release product (generic).
-
FDA approval · 2007-09-28FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for STRATTERA (atomoxetine hydrochloride) submitted by Eli Lilly and Company. This action update…
-
FDA approval · 2007-08-31FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for Dextroamphetamine Sulfate Extended-Release, a generic product manufactured by SpecGx LLC.
-
FDA approval · 2007-08-31FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Dextroamphetamine sulfate from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2007-06-07FDA Approved: METHYLIN — Supplemental Application (SHIONOGI INC.)
FDA approved a supplemental application for Methylin (methylphenidate hydrochloride) from Shionogi Inc. The action indicates regulatory appr…
-
FDA approval · 2007-05-22FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for a combination of four amphetamine salt–forms (dextroamphetamine sacchar…
-
FDA approval · 2007-05-04FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for methylphenidate hydrochloride CD from Lannett Company, Inc., under NDA 021259.
-
FDA approval · 2007-05-03FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2007-05-01FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
FDA approved a supplemental application for the Methylphenidate Transdermal System submitted by Padagis US LLC for the treatment of attentio…
-
FDA approval · 2007-05-01FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) from Amneal Pharmaceuticals LLC.
-
FDA approval · 2007-04-25FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) from Sandoz Inc, resulting in an approved modi…
-
FDA approval · 2007-04-25FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental NDA for FOCALIN (dexmethylphenidate hydrochloride) from Sandoz Inc, indicating an approved change to the existin…
-
FDA approval · 2007-04-25FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2007-04-25FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) submitted by Eli Lilly and Company.
-
FDA approval · 2007-04-25FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for methylphenidate from Sandoz Inc, indicating an approved change to the product's labeling or …
-
FDA approval · 2007-03-23FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for Dextroamphetamine Sulfate Extended-Release submitted by SpecGx LLC. This action pertains to …